HEADER HYDROLASE 20-AUG-24 9GJ2 TITLE CRYSTAL STRUCTURE OF HUMAN CATHEPSIN S PRODUCED IN INSECT CELLS IN TITLE 2 COMPLEX WITH KETOAMIDE 13B COMPND MOL_ID: 1; COMPND 2 MOLECULE: CATHEPSIN S; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.22.27; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CTSS; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS CYSTEINE PROTEASE, DRUG TARGET, THIOHEMIKETAL, MAIN PROTEASE KEYWDS 2 INHIBITOR, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.FALKE,K.KARNICAR,A.USENIK,N.LINDIC,A.SEKIRNIK,P.Y.A.REINKE, AUTHOR 2 S.GUENTHER,D.TURK,A.MEENTS REVDAT 1 04-SEP-24 9GJ2 0 JRNL AUTH S.FALKE,K.KARNICAR,A.USENIK,N.LINDIC,A.SEKIRNIK, JRNL AUTH 2 P.Y.A.REINKE,S.GUENTHER,D.TURK,A.MEENTS JRNL TITL CRYSTAL STRUCTURE OF HUMAN CATHEPSIN S PRODUCED IN INSECT JRNL TITL 2 CELLS IN COMPLEX WITH KETOAMIDE 13B JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.21.1-5286_9999 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.52 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 3 NUMBER OF REFLECTIONS : 353348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.151 REMARK 3 R VALUE (WORKING SET) : 0.151 REMARK 3 FREE R VALUE : 0.162 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.090 REMARK 3 FREE R VALUE TEST SET COUNT : 3837 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.5200 - 3.4500 1.00 14207 159 0.1446 0.1506 REMARK 3 2 3.4500 - 2.7400 1.00 14244 162 0.1626 0.1752 REMARK 3 3 2.7400 - 2.3900 1.00 14176 155 0.1581 0.1308 REMARK 3 4 2.3900 - 2.1700 1.00 14228 155 0.1491 0.1760 REMARK 3 5 2.1700 - 2.0200 1.00 14249 156 0.1391 0.1578 REMARK 3 6 2.0200 - 1.9000 1.00 14175 156 0.1357 0.1374 REMARK 3 7 1.9000 - 1.8000 1.00 14211 156 0.1356 0.1670 REMARK 3 8 1.8000 - 1.7300 1.00 14203 154 0.1430 0.1795 REMARK 3 9 1.7300 - 1.6600 1.00 14217 159 0.1277 0.1394 REMARK 3 10 1.6600 - 1.6000 1.00 14207 158 0.1205 0.1367 REMARK 3 11 1.6000 - 1.5500 1.00 14217 153 0.1211 0.1288 REMARK 3 12 1.5500 - 1.5100 1.00 14200 154 0.1204 0.1599 REMARK 3 13 1.5100 - 1.4700 1.00 14239 156 0.1214 0.1688 REMARK 3 14 1.4700 - 1.4300 1.00 14171 158 0.1250 0.1136 REMARK 3 15 1.4300 - 1.4000 1.00 14213 153 0.1288 0.1265 REMARK 3 16 1.4000 - 1.3700 1.00 14187 154 0.1357 0.1570 REMARK 3 17 1.3700 - 1.3400 1.00 14180 151 0.1560 0.1694 REMARK 3 18 1.3400 - 1.3200 0.99 14105 159 0.1641 0.1882 REMARK 3 19 1.3200 - 1.2900 0.98 13951 149 0.1764 0.1927 REMARK 3 20 1.2900 - 1.2700 0.94 13428 148 0.1949 0.1947 REMARK 3 21 1.2700 - 1.2500 0.87 12303 134 0.2125 0.1740 REMARK 3 22 1.2500 - 1.2300 0.81 11473 127 0.2285 0.2369 REMARK 3 23 1.2300 - 1.2100 0.74 10547 115 0.2519 0.2625 REMARK 3 24 1.2100 - 1.2000 0.68 9685 106 0.2844 0.2978 REMARK 3 25 1.2000 - 1.1800 0.61 8665 96 0.3005 0.3882 REMARK 3 26 1.1800 - 1.1600 0.54 7673 84 0.3195 0.3275 REMARK 3 27 1.1600 - 1.1500 0.43 6157 70 0.3522 0.3883 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.108 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.322 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 3685 REMARK 3 ANGLE : 0.745 4989 REMARK 3 CHIRALITY : 0.076 499 REMARK 3 PLANARITY : 0.006 666 REMARK 3 DIHEDRAL : 15.250 1375 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9GJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-AUG-24. REMARK 100 THE DEPOSITION ID IS D_1292140884. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-MAY-24 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, DESY REMARK 200 BEAMLINE : P11 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.033190 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER2 X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 353434 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.150 REMARK 200 RESOLUTION RANGE LOW (A) : 47.520 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 11.70 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.16 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CATHEPSIN S (7 MG/ML) WAS MIXED WITH REMARK 280 AN EQUAL VOLUME OF RESERVOIR AND EQUILIBRATED AGAINST 20% (W/V) REMARK 280 PEG4000, 0.2 M AMMONIUM SULFATE, 0.1 M SODIUM CITRATE PH 4.6. REMARK 280 CRYSTALS WERE SOAKED WITH KETOAMIDE 13B IN THE PRESENCE OF 5% (V/ REMARK 280 V) DMSO., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.02250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 38.01125 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 114.03375 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 76.02250 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 114.03375 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 38.01125 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 509 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 220 REMARK 465 GLU A 221 REMARK 465 ASN A 222 REMARK 465 LEU A 223 REMARK 465 TYR A 224 REMARK 465 PHE A 225 REMARK 465 GLN A 226 REMARK 465 SER A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 GLY A 230 REMARK 465 VAL A 231 REMARK 465 ASP A 232 REMARK 465 LEU A 233 REMARK 465 GLY A 234 REMARK 465 THR A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 ILE B 0 REMARK 465 GLU B 221 REMARK 465 ASN B 222 REMARK 465 LEU B 223 REMARK 465 TYR B 224 REMARK 465 PHE B 225 REMARK 465 GLN B 226 REMARK 465 SER B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 GLY B 230 REMARK 465 VAL B 231 REMARK 465 ASP B 232 REMARK 465 LEU B 233 REMARK 465 GLY B 234 REMARK 465 THR B 235 REMARK 465 HIS B 236 REMARK 465 HIS B 237 REMARK 465 HIS B 238 REMARK 465 HIS B 239 REMARK 465 HIS B 240 REMARK 465 HIS B 241 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 58 -128.14 -115.52 REMARK 500 ARG A 141 57.50 -92.08 REMARK 500 LYS A 202 53.41 -119.88 REMARK 500 CYS A 206 18.80 59.71 REMARK 500 THR B 58 -126.57 -113.19 REMARK 500 LYS B 202 54.89 -118.31 REMARK 500 CYS B 206 17.91 59.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 624 DISTANCE = 5.82 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8PRX RELATED DB: PDB DBREF 9GJ2 A 0 217 UNP P25774 CATS_HUMAN 114 331 DBREF 9GJ2 B 0 217 UNP P25774 CATS_HUMAN 114 331 SEQADV 9GJ2 ALA A 218 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ALA A 219 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ALA A 220 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLU A 221 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ASN A 222 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 LEU A 223 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 TYR A 224 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 PHE A 225 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLN A 226 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER A 227 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER A 228 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER A 229 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLY A 230 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 VAL A 231 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ASP A 232 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 LEU A 233 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLY A 234 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 THR A 235 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 236 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 237 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 238 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 239 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 240 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS A 241 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ALA B 218 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ALA B 219 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ALA B 220 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLU B 221 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ASN B 222 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 LEU B 223 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 TYR B 224 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 PHE B 225 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLN B 226 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER B 227 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER B 228 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 SER B 229 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLY B 230 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 VAL B 231 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 ASP B 232 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 LEU B 233 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 GLY B 234 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 THR B 235 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 236 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 237 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 238 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 239 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 240 UNP P25774 EXPRESSION TAG SEQADV 9GJ2 HIS B 241 UNP P25774 EXPRESSION TAG SEQRES 1 A 242 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 A 242 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA CYS SEQRES 3 A 242 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 A 242 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 A 242 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 A 242 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 A 242 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 A 242 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 A 242 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 A 242 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 A 242 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 A 242 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 A 242 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 A 242 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 A 242 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 A 242 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 A 242 ILE ALA SER PHE PRO SER TYR PRO GLU ILE ALA ALA ALA SEQRES 18 A 242 GLU ASN LEU TYR PHE GLN SER SER SER GLY VAL ASP LEU SEQRES 19 A 242 GLY THR HIS HIS HIS HIS HIS HIS SEQRES 1 B 242 ILE LEU PRO ASP SER VAL ASP TRP ARG GLU LYS GLY CYS SEQRES 2 B 242 VAL THR GLU VAL LYS TYR GLN GLY SER CYS GLY ALA CYS SEQRES 3 B 242 TRP ALA PHE SER ALA VAL GLY ALA LEU GLU ALA GLN LEU SEQRES 4 B 242 LYS LEU LYS THR GLY LYS LEU VAL SER LEU SER ALA GLN SEQRES 5 B 242 ASN LEU VAL ASP CYS SER THR GLU LYS TYR GLY ASN LYS SEQRES 6 B 242 GLY CYS ASN GLY GLY PHE MET THR THR ALA PHE GLN TYR SEQRES 7 B 242 ILE ILE ASP ASN LYS GLY ILE ASP SER ASP ALA SER TYR SEQRES 8 B 242 PRO TYR LYS ALA MET ASP GLN LYS CYS GLN TYR ASP SER SEQRES 9 B 242 LYS TYR ARG ALA ALA THR CYS SER LYS TYR THR GLU LEU SEQRES 10 B 242 PRO TYR GLY ARG GLU ASP VAL LEU LYS GLU ALA VAL ALA SEQRES 11 B 242 ASN LYS GLY PRO VAL SER VAL GLY VAL ASP ALA ARG HIS SEQRES 12 B 242 PRO SER PHE PHE LEU TYR ARG SER GLY VAL TYR TYR GLU SEQRES 13 B 242 PRO SER CYS THR GLN ASN VAL ASN HIS GLY VAL LEU VAL SEQRES 14 B 242 VAL GLY TYR GLY ASP LEU ASN GLY LYS GLU TYR TRP LEU SEQRES 15 B 242 VAL LYS ASN SER TRP GLY HIS ASN PHE GLY GLU GLU GLY SEQRES 16 B 242 TYR ILE ARG MET ALA ARG ASN LYS GLY ASN HIS CYS GLY SEQRES 17 B 242 ILE ALA SER PHE PRO SER TYR PRO GLU ILE ALA ALA ALA SEQRES 18 B 242 GLU ASN LEU TYR PHE GLN SER SER SER GLY VAL ASP LEU SEQRES 19 B 242 GLY THR HIS HIS HIS HIS HIS HIS HET KH0 A 301 43 HET EDO A 302 4 HET EDO A 303 4 HET DMS A 304 4 HET DMS A 305 4 HET KH0 B 301 43 HET EDO B 302 4 HET CIT B 303 13 HET EDO B 304 10 HETNAM KH0 ~{TERT}-BUTYL ~{N}-[1-[(2~{S})-3-CYCLOPROPYL-1- HETNAM 2 KH0 OXIDANYLIDENE-1-[[(2~{S},3~{S})-3-OXIDANYL-4- HETNAM 3 KH0 OXIDANYLIDENE-1-[(3~{S})-2-OXIDANYLIDENEPYRROLIDIN-3- HETNAM 4 KH0 YL]-4-[(PHENYLMETHYL)AMINO]BUTAN-2-YL]AMINO]PROPAN-2- HETNAM 5 KH0 YL]-2-OXIDANYLIDENE-PYRIDIN-3-YL]CARBAMATE HETNAM EDO 1,2-ETHANEDIOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM CIT CITRIC ACID HETSYN KH0 (S,S,S)-13B; KETOAMIDE INHIBITOR 13B (BOUND) HETSYN EDO ETHYLENE GLYCOL FORMUL 3 KH0 2(C31 H41 N5 O7) FORMUL 4 EDO 4(C2 H6 O2) FORMUL 6 DMS 2(C2 H6 O S) FORMUL 10 CIT C6 H8 O7 FORMUL 12 HOH *446(H2 O) HELIX 1 AA1 ARG A 8 GLY A 11 5 4 HELIX 2 AA2 ALA A 24 GLY A 43 1 20 HELIX 3 AA3 SER A 49 SER A 57 1 9 HELIX 4 AA4 THR A 58 GLY A 62 5 5 HELIX 5 AA5 LYS A 64 GLY A 68 5 5 HELIX 6 AA6 PHE A 70 LYS A 82 1 13 HELIX 7 AA7 ASP A 102 LYS A 104 5 3 HELIX 8 AA8 ARG A 120 LYS A 131 1 12 HELIX 9 AA9 HIS A 142 TYR A 148 1 7 HELIX 10 AB1 ASN A 204 ILE A 208 5 5 HELIX 11 AB2 ARG B 8 GLY B 11 5 4 HELIX 12 AB3 ALA B 24 GLY B 43 1 20 HELIX 13 AB4 SER B 49 SER B 57 1 9 HELIX 14 AB5 THR B 58 GLY B 62 5 5 HELIX 15 AB6 LYS B 64 GLY B 68 5 5 HELIX 16 AB7 PHE B 70 LYS B 82 1 13 HELIX 17 AB8 ASP B 102 LYS B 104 5 3 HELIX 18 AB9 ARG B 120 LYS B 131 1 12 HELIX 19 AC1 HIS B 142 LEU B 147 1 6 HELIX 20 AC2 ASN B 204 ILE B 208 5 5 SHEET 1 AA1 3 VAL A 5 ASP A 6 0 SHEET 2 AA1 3 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA1 3 VAL A 134 VAL A 138 -1 N VAL A 134 O VAL A 168 SHEET 1 AA2 5 VAL A 5 ASP A 6 0 SHEET 2 AA2 5 HIS A 164 LEU A 174 -1 O TYR A 171 N VAL A 5 SHEET 3 AA2 5 LYS A 177 LYS A 183 -1 O LYS A 183 N LEU A 167 SHEET 4 AA2 5 TYR A 195 ALA A 199 -1 O MET A 198 N TRP A 180 SHEET 5 AA2 5 VAL A 152 TYR A 153 1 N TYR A 153 O ARG A 197 SHEET 1 AA3 2 ILE A 84 ASP A 85 0 SHEET 2 AA3 2 ARG A 106 ALA A 108 -1 O ALA A 107 N ILE A 84 SHEET 1 AA4 2 LYS A 112 GLU A 115 0 SHEET 2 AA4 2 SER A 213 GLU A 216 -1 O GLU A 216 N LYS A 112 SHEET 1 AA5 3 VAL B 5 ASP B 6 0 SHEET 2 AA5 3 HIS B 164 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 AA5 3 VAL B 134 VAL B 138 -1 N VAL B 134 O VAL B 168 SHEET 1 AA6 5 VAL B 5 ASP B 6 0 SHEET 2 AA6 5 HIS B 164 LEU B 174 -1 O TYR B 171 N VAL B 5 SHEET 3 AA6 5 LYS B 177 LYS B 183 -1 O LYS B 183 N LEU B 167 SHEET 4 AA6 5 TYR B 195 ALA B 199 -1 O MET B 198 N TRP B 180 SHEET 5 AA6 5 VAL B 152 TYR B 153 1 N TYR B 153 O ARG B 197 SHEET 1 AA7 2 ILE B 84 ASP B 85 0 SHEET 2 AA7 2 ARG B 106 ALA B 108 -1 O ALA B 107 N ILE B 84 SHEET 1 AA8 2 LYS B 112 GLU B 115 0 SHEET 2 AA8 2 SER B 213 GLU B 216 -1 O GLU B 216 N LYS B 112 SSBOND 1 CYS A 22 CYS A 66 1555 1555 2.03 SSBOND 2 CYS A 56 CYS A 99 1555 1555 2.06 SSBOND 3 CYS A 158 CYS A 206 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 66 1555 1555 2.04 SSBOND 5 CYS B 56 CYS B 99 1555 1555 2.06 SSBOND 6 CYS B 158 CYS B 206 1555 1555 2.04 LINK SG CYS A 25 C57 KH0 A 301 1555 1555 1.78 LINK SG CYS B 25 C57 KH0 B 301 1555 1555 1.78 CRYST1 86.102 86.102 152.045 90.00 90.00 90.00 P 41 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011614 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011614 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006577 0.00000